These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11362543)

  • 1. Turning the corner on wasting? A symposium on wasting disorders.
    Getty J
    BETA; 1995 Jun; ():33-7. PubMed ID: 11362543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State of the art in wasting: an interview with Carl Grunfeld, PhD. Interview by Jeff Getty.
    Grunfeld C
    BETA; 1995 Jun; ():34-7. PubMed ID: 11362544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No attrition in research on wasting therapies.
    Gilden D
    GMHC Treat Issues; 1997; 11(4/5):9, 12-6. PubMed ID: 11364378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS activists secure approval for human growth hormone (Serostim).
    Crit Path AIDS Proj; 1996; (No 31):34. PubMed ID: 11363832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wasting in the acquired immunodeficiency syndrome.
    Grunfeld C; Kotler DP
    Semin Liver Dis; 1992 May; 12(2):175-87. PubMed ID: 1636120
    [No Abstract]   [Full Text] [Related]  

  • 6. Wasting syndrome--affordable treatments.
    James JS
    AIDS Treat News; 1995 Jul; (no 226):6-7. PubMed ID: 11362615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New drug to treat wasting syndrome.
    Common Factor; 1995 Apr; (no 10):19. PubMed ID: 11362344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wasting syndrome in AIDS: pathophysiologic mechanisms and therapeutic approaches.
    Weinroth SE; Parenti DM; Simon GL
    Infect Agents Dis; 1995 Jun; 4(2):76-94. PubMed ID: 7613731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone cut down at the pass.
    Gilden D
    GMHC Treat Issues; 1996 Mar; 10(3):6. PubMed ID: 11363391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone replacement, weight lifting help wasting.
    AIDS Alert; 1996 Jun; 11(6):suppl 1-2. PubMed ID: 11363546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.
    Gelato M; McNurlan M; Freedland E
    Clin Ther; 2007 Nov; 29(11):2269-88. PubMed ID: 18158071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide: new expanded access for wasting.
    James JS
    AIDS Treat News; 1995 Sep; (no 230):6. PubMed ID: 11362760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human growth hormone not recommended for approval on narrow advisory panel vote.
    James JS
    AIDS Treat News; 1996 Mar; (no 243):6-7. PubMed ID: 11363301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide for wasting syndrome: progress toward compromise.
    James JS
    AIDS Treat News; 1995 Nov; (no 234):1-5. PubMed ID: 11363041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticytokine approaches to the treatment of anorexia and cachexia.
    Haslett PA
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):53-7. PubMed ID: 9625384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wider access to human growth hormone.
    Baker R
    BETA; 1995 Sep; ():8, 10. PubMed ID: 11362898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide Celgene Corp.
    Bruyn GA
    IDrugs; 1998 Aug; 1(4):490-500. PubMed ID: 18465584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growing interest in thalidomide.
    Lowell B
    GMHC Treat Issues; 1995 May; 9(5):4-6. PubMed ID: 11362414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nutritional status of patients with HIV-AIDS infection].
    López-Herce JA
    An Med Interna; 1998 Dec; 15(12):623-6. PubMed ID: 9972594
    [No Abstract]   [Full Text] [Related]  

  • 20. Thalidomide's elusive access.
    Gilden D
    GMHC Treat Issues; 1995 Nov; 9(11):11-2. PubMed ID: 11362987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.